Navigation Links
CBaySystems' Commitment to Continued Improvement Leads to High Industry Recognition
Date:1/28/2008

Independent research firm KLAS ranks CBaySystems as 'most improved' in its

2007 MTSO study

ANNAPOLIS, Md., Jan. 28 /PRNewswire/ -- CBaySystems, a leading provider of transcription and healthcare BPO services, announces its recognition as the most improved MTSO (Medical Transcription Service Organization) for 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070625/NEM130LOGO )

An independent research and consulting firm, KLAS conducted confidential interviews with healthcare IT executives and department directors to evaluate each MTSO across 17 performance areas. CBaySystems was found to be the one of only two companies to have a positive trend rating increase in all three major categories: Performance Indicators, Business Indicators, and Percentage of Positive Commentary. KLAS also reported "CBay has made the biggest jump in the last year in customer satisfaction."

CBaySystems attributes this continued success to a number of improvements and advancements made to their products and services. More specifically, in August 2007 CBay partnered with eScription -- the leader in Computer Aided Medical Transcription (CAMT) software -- to enhance their product offerings. Also evaluated under a separate KLAS study in 2007, eScription received the Best in KLAS award for the fourth year in a row, with its software ranking #1 in the category of Transcription and Back-End Speech Recognition.

CBaySystems also conducts annual customer satisfaction surveys to ensure they're maintaining high levels of quality and service. The 2007 survey showed an increase in the percentage of customers that would recommend CBay services to others, up to 95%. It also found that 96% of CBay customers rated service as "good and above," another increase from the previous year.

"Our commitment to improvement has earned us recognition that we're
'/>"/>

SOURCE CBaySystems
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. CBaySystems Again Named to the Baltimore List of Fastest Growing Companies
2. CBaySystems and M*Modal Enter Strategic Partnership
3. CBaySystems Introduces CBayPraxis - A Breakthrough Solution Focused on Physician Practice Efficiency
4. CBaySystems Gives Away 2008 Honda Civic at AHIMA 2007
5. CBaySystems Selected to Receive Deloittes 2007 Maryland Technology Fast 50 Award
6. CBaySystems to Give Away a 2008 Honda Civic at AHIMA 2007
7. Equal level of commitment and relationship satisfaction found among gay and heterosexual couples
8. Lung Cancer Alliance Praises Congressional Call for Increased Commitment to Fund Lung Cancer Research
9. Malaria Community Applauds Clintons $1 Billion a Year Pledge; Invites Other Candidates to Make Malaria Commitments
10. The American Diabetes Association Expands Commitment to Youth With Type 1 Diabetes
11. AMA Commends Aetna for Quality First Commitment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., Dec. 4 The large, two-day free h... of Free Clinics (NAFC) in Kansas City on Wednesda...or anyone who is uninsured and has not seen a doct... will receive preventive primary care. ,, "Man...e clinic events this fall in Houston, New Orleans ...
(Date:12/4/2009).... 4 While Congress deba...h care costs, Leapfrog,s purchaser members point t...ring the best quality care in the nation while att...ur urban, eight children,s and three rural hospita...sed on results from The Leapfrog Hospital Survey. ...
(Date:12/4/2009)... new study shows that muscle cells grown in the la...ut properly. The work, performed in dogs and rats,...ons such as gastric reflux and fecal incontinence....ncters, which are the bands of muscle that separat...kness in these areas can cause gastrointestinal es...
(Date:12/4/2009)...icans are recruited annually to participate in cli...esearch Protection (AHRP), and most will be compen...stitutions view payments to volunteers as compensa...r potential risks related to participating in the ...s have a very different view of clinical trial com...
(Date:12/4/2009)...re done immediately or 3 weeks later, study shows ...iming of surgical repair or reconstruction of mult... outcome, a new study has found. , Multiple-lig...locations that can occur in high-impact car crashe...m surgery to repair these injuries hasn,t been def...
Breaking Medicine News(10 mins):Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
...nologies Inc., a,leading developer and manufacture...today announced that the company has entered into ... with LightLab imaging.,Under this multi- year exc... system., (Photo: http://www.newscom.com/cgi-bin...
.... (San Francisco, CA,and Ottawa, Canada), announce...delivered a plenary session presentation on Friday... with JX-594, a Novel Targeted,Multi-Mechanistic O...his abstract was selected for presentation in the,...
...ata Demonstrating Superiority of XIENCE ...KYO, June 2 Abbott (NYSE: ABT ) today,announced ...bai Shonin,(Marketing Authorization License) to Ja...s Eluting Coronary Stent System to,treat coronary ...
...(OTC,Bulletin Board: IAGX) announced today that it...aVie LLC (http://www.monavie.com ) that provides ... Celadrin, a cellular lubricant, is a joint healt...ty.,Celadrin is a unique, scientifically arranged ...
...k II anaerobic,system for the cultivation of anaer... an excellent alternative to the use of anaerobic ...aboratories. The Anoxomat Mark II,automatic jar ev...the way the Anoxomat jar works, I can open it up, ...
..., kept tumors stable for almost 6 months , ...n therapy of gemcitabine, capecitabine and bevaciz...ancreatic cancer, according to a multi-center stud...ated by patients, was able to prevent tumors from ...
Other Medicine News:Health News:Axsun Technologies Announces Exclusive Cardiac Supply Agreement for Advanced OCT Tunable Lasers with LightLab Imaging 2Health News:Jennerex Clinical Trial Data with JX-594 Selected for Plenary Session Presentation at Major International Conference 2Health News:Jennerex Clinical Trial Data with JX-594 Selected for Plenary Session Presentation at Major International Conference 3Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 2Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 3Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 4Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 5Health News:Imagenetix Enters into Business Relationship with MonaVie 2Health News:Advanced Instruments' Anoxomat Mark II Anaerobic System is Excellent Alternative to Anaerobic Chambers, Gas Bags in Clinical Laboratories 2Health News:Advanced Instruments' Anoxomat Mark II Anaerobic System is Excellent Alternative to Anaerobic Chambers, Gas Bags in Clinical Laboratories 3
(Date:12/4/2009)... , MORRISTOWN, N.J., Dec. 4 /PRNewswire-FirstC...), a leading global specialty pharmaceutical compa...boratories, Inc.-Florida, filed an Abbreviated New...ug Administration seeking approval to market its 8...patent owned by Takeda Pharmaceutical Company Limi...
(Date:12/4/2009)... , WILMINGTON, Del., Dec. 4 /PRNewswire-FirstCa...that the US Food and Drug Administration (FDA) has... fumarate) Extended Release Tablets as adjunctive ...th Major Depressive Disorder (MDD). SEROQUEL XR is...FDA to treat both major depressive disorder as adj...
(Date:12/3/2009)... , ALISO VIEJO, Calif. and STATE COLLEGE, Pa.,...etics today announced the signing of an agreement ...es using SoftGenetics, NextGENe software for next-... ,, (Logo: http://www.newscom.com/cgi-bin/p...PhD, Ambry,s CSO said, "Our team at Ambry has been...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 1Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 2Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 3Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 4Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 5Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 6Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 7Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 8Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 1Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 2Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 3HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 1HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 2HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 3
Complete brand Blink-N-Clean Lens Drops
Renu Preservative Free Lubricating and Rewetting Drops
Sterile Preserved Saline Solution
Sensitive Eyes Plus Saline Solution
Medicine Products: